Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Expression of human DNA Topoisomerase II-alpha in squamous cell carcinoma of the larynx and its correlation with clinicopathologic variables.

Shvero J, Koren R, Shvili I, Yaniv E, Sadov R, Hadar T.

Am J Clin Pathol. 2008 Dec;130(6):934-9. doi: 10.1309/AJCPROG61USKCBEI.

PMID:
19019771
2.

Prognostic value of Topoisomerase II in female breast cancer.

Koren R, Rath-Wolfson L, Ram E, Itzhac OB, Schachter B, Klein B, Gal R, Dreznik Z.

Oncol Rep. 2004 Oct;12(4):915-9.

PMID:
15375522
3.

DNA topoisomerase II-alpha as a proliferation marker in human gliomas: correlation with PCNA expression and patient survival.

Zhao H, Yu H, Liu Y, Wang Y, Cai W.

Clin Neuropathol. 2008 Mar-Apr;27(2):83-90.

PMID:
18402387
4.

Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.

Stathopoulos GP, Kapranos N, Manolopoulos L, Papadimitriou C, Adamopoulos G.

Anticancer Res. 2000 Jan-Feb;20(1A):177-82.

PMID:
10769652
5.

Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer.

Lynch BJ, Guinee DG Jr, Holden JA.

Hum Pathol. 1997 Oct;28(10):1180-8.

PMID:
9343325
7.
8.

Expression of cyclooxygenase-2 and DNA topoisomerase II alpha in precancerous and cancerous lesions of the oral mucosa.

Segawa E, Sakurai K, Kishimoto H, Takaoka K, Noguchi K, Hashitani S, Hirota S, Urade M.

Oral Oncol. 2008 Jul;44(7):664-71. Epub 2007 Nov 9.

PMID:
17996482
9.

Topoisomerase II alpha expression correlates with diminished disease-free survival in invasive breast cancer.

O'Connor JK, Hazard LJ, Avent JM, Lee RJ, Fischbach J, Gaffney DK.

Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1411-5. Epub 2006 Jun 5.

PMID:
16750309
10.

Topoisomerase II alpha expression in esophageal squamous cell carcinoma.

Ohashi Y, Sasano H, Yamaki H, Shizawa S, Kikuchi A, Shineha R, Akaishi T, Satomi S, Nagura H.

Anticancer Res. 1999 May-Jun;19(3A):1873-80.

PMID:
10470130
11.

Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon.

Staley BE, Samowitz WS, Bronstein IB, Holden JA.

Mod Pathol. 1999 Apr;12(4):356-61.

PMID:
10229499
12.

Prognostic significance of DNA topoisomerase IIalpha expression in human hepatocellular carcinoma. .

Watanuki A, Ohwada S, Fukusato T, Makita F, Yamada T, Kikuchi A, Morishita Y.

Anticancer Res. 2002 Mar-Apr;22(2B):1113-9.

PMID:
12168909
13.
14.

Human DNA topoisomerase II-alpha expression in laparoscopically treated renal cell carcinoma.

Dekel Y, Frede T, Kugel V, Neumann G, Rassweiler J, Koren R.

Oncol Rep. 2005 Jul;14(1):271-4.

PMID:
15944800
15.

Unique cell membrane expression of topoisomerase-II alpha as a useful diagnostic marker of liposarcoma.

Endo H, Hirokawa M, Ishimaru N, Tanaka Y, Yamashita M, Sakaki M, Hayashi Y, Sano T.

Pathol Int. 2004 Mar;54(3):145-50.

PMID:
14989736
16.

Topoisomerase II alpha expression in breast ductal invasive carcinomas and correlation with clinicopathological variables.

Kalogeraki A, Ieromonachou P, Kafousi M, Giannikaki E, Vrekoussis T, Zoras O, Tsiftsis D, Delides G, Stathopoulos E.

In Vivo. 2005 Sep-Oct;19(5):837-40.

17.

Human DNA topoisomerase-IIalpha expression as a prognostic factor for transitional cell carcinoma of the urinary bladder.

Koren R, Kugel V, Dekel Y, Weissman Y, Livne PM, Gal R.

BJU Int. 2003 Apr;91(6):489-92.

18.

Topoisomerase II-alpha expression in different cell cycle phases in fresh human breast carcinomas.

Villman K, Ståhl E, Liljegren G, Tidefelt U, Karlsson MG.

Mod Pathol. 2002 May;15(5):486-91.

19.

Expression of topoisomerase II alpha, Ki-67 and p53 in early stage laryngeal carcinomas not featuring vocal cord fixation.

Horibe Y, Murakami M, Komori K, Imaeda Y, Kasahara M.

APMIS. 2000 Oct;108(10):689-96.

PMID:
11200824
20.

Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.

Tanoguchi K, Sasano H, Yabuki N, Kikuchi A, Ito K, Sato S, Yajima A.

Mod Pathol. 1998 Feb;11(2):186-93.

PMID:
9504690

Supplemental Content

Support Center